Longitudinal reduction of quality of life in patients with epilepsy and no seizure increase during the COVID-19 pandemic
|Title||Longitudinal reduction of quality of life in patients with epilepsy and no seizure increase during the COVID-19 pandemic|
|Publication Type||Conference Paper|
|Year of Publication||2021|
|Authors||Gonzalez-Martinez, A., Á. Planchuelo-Gómez, A. Vieira, F. Martínez-Dubarbie, J. Vivancos, and M. De Toledo|
|Conference Name||7th Congress of the European Academy of Neurology|
|Conference Location||Virtual Congress|
Background and aims: In early 2020, the novel coronavirus disease (COVID-19) pandemic has impaired medical care of chronic neurological diseases, including epilepsy. The objective of this study is to evaluate the impact of the COVID-19 pandemic in the levels of anxiety, depression, somnolence and quality of life using validated scales in patients with epilepsy in real-life clinical practice.